The ROE as of November 2024 (TTM) for Praxis Precision Medicines, Inc. (PRAX) is -61.47%

According to Praxis Precision Medicines, Inc.’s latest financial reports and current stock price. The company's current ROE is -61.47%. This represents a change of 167.29% compared to the average of -23.00% of the last 4 quarters.

Praxis Precision Medicines, Inc. (PRAX) Historical ROE (quarterly & annually)

How has PRAX ROE performed in the past?

The mean historical ROE of Praxis Precision Medicines, Inc. over the last ten years is -135.70%. The current -61.47% ROE has changed -54.70% with respect to the historical average. Over the past ten years (40 quarters), PRAX's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the June 2020 quarter at -82.01%.

Praxis Precision Medicines, Inc. (PRAX) ROE by Quarter and Year

Discovering the peaks and valleys of Praxis Precision Medicines, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Praxis Precision Medicines, Inc. (PRAX) Average ROE

How has PRAX ROE performed in the past?

The current ROE of Praxis Precision Medicines, Inc. (PRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Praxis Precision Medicines, Inc. (PRAX) ROE vs. Peers

How is PRAX’s ROE compared to its peers?

Praxis Precision Medicines, Inc.’s ROE is greater than Molecular Partners AG (-33.08%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Pharvaris N.V. (-36.89%), greater than PepGen Inc. (-62.74%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Enliven Therapeutics, Inc. (-29.31%), greater than Immuneering Corporation (-66.03%), greater than Anebulo Pharmaceuticals, Inc. (-138.92%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than HCW Biologics Inc. (-385.90%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Crinetics Pharmaceuticals, Inc. (-62.63%), greater than Dyne Therapeutics, Inc. (-68.85%), greater than Revolution Medicines, Inc. (-34.57%),

Build a custom stock screener for Praxis Precision Medicines, Inc. (PRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Praxis Precision Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Praxis Precision Medicines, Inc. (PRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Praxis Precision Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.